Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 47 | 0 | 5 | 0 | €684.00 | €755.83 | 10.502% |
| Vertex Pharmaceuticals Inc. | 39 | 2 | 4 | 0 | €369.90 | €382.71 | 3.462% |
| Boston Scientific | 37 | 0 | 4 | 0 | €63.50 | €61.53 | -3.109% |
| Intuitive Surgical Inc | 35 | 0 | 3 | 0 | €347.25 | €368.20 | 6.033% |
| UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | €473.15 | €543.72 | 14.915% |
| Regeneron Pharmaceuticals Inc. | 31 | 1 | 5 | 1 | €838.20 | €954.29 | 13.850% |
| Merck & Co. Inc. | 27 | 1 | 4 | 0 | €117.40 | €124.92 | 6.402% |
| Thermo Fisher Scientific Inc. | 24 | 0 | 3 | 0 | €508.30 | €561.51 | 10.467% |
| Amgen Inc. | 23 | 0 | 3 | 0 | €250.05 | €293.65 | 17.436% |
| Edwards Lifesciences Corp. | 24 | 1 | 4 | 0 | €80.57 | €87.81 | 8.982% |
| Cytokinetics Inc. | 24 | 1 | 4 | 0 | €62.50 | €88.82 | 42.117% |
| Intra-Cellular Therapies Inc. | 21 | 0 | 5 | 0 | €69.00 | €77.61 | 12.482% |
| Neurocrine Bioscience | 21 | 0 | 3 | 0 | €127.00 | €137.10 | 7.953% |
| Humana Inc. | 20 | 0 | 3 | 0 | €309.50 | €473.29 | 52.919% |
| HCA Holdings Inc. | 19 | 0 | 2 | 0 | €280.10 | €289.08 | 3.204% |